FIELD: medicine.
SUBSTANCE: androgens are introduced into the body under laboratory control of testosterone. An androgen source is dermal administration of the preparation androgel 5 g in the interval of 48-72 hours in a pulse mode for 2-3 months. After laboratory control additionally involving the serum analysis for intestinal cell-stimulating and follicle-stimulating hormones, sex hormone binding globulin, prostatic specific antigen, sperm fertility, the dermal administration of androgens is continued for another 2-4 months. If the above values fall beyond the norms, the prescribed androgens are withdrawn for 2-4 months.
EFFECT: invention provides preventing side effects of substitution androgen therapy.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPY OF PATIENTS SUFFERING FROM CHRONIC PROSTATITIS | 2008 |
|
RU2364402C1 |
| DIAGNOSTIC TECHNIQUE FOR LATENT ANDROGEN DEFICIENCY IN MEN | 2008 |
|
RU2380036C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF FORM OF ERECTILE DYSFUNCTION | 2011 |
|
RU2460462C1 |
| DIAGNOSTIC TECHNIQUE FOR HORMONAL DISORDERS IN MEN | 2019 |
|
RU2715565C1 |
| SCREENING METHOD FOR DETECTING IMMUNE METABOLIC POLYPATHIES IN YOUNG INDIVIDUALS (VERSIONS) | 2014 |
|
RU2547609C1 |
| METHOD OF SUBSTITUTION THERAPY OF AGE ANDROGENIC DEFICIENCY WITH STIMULATION OF ENDOGENOUS TESTOSTERONE PRODUCING | 1999 |
|
RU2179025C2 |
| METHOD FOR INTEGRATED TREATMENT OF PATHOZOOSPERMIA IN MALES SUFFERING ADRENAL HYPERANDROGENISM | 2012 |
|
RU2510284C1 |
| METHOD OF DIAGNOSING ANDROGENIC DEFICIENCY | 2010 |
|
RU2439578C1 |
| METHOD OF SUBSTITUTION THERAPY IN MEN WITH AGE ANDROGENIC DEFICIENCY | 1999 |
|
RU2179443C2 |
| METHOD OF PREDICTION OF CLINICAL EFFECTIVENESS OF TREATMENT WITH CHORIONIC GONADOTROPIN IN MALES WITH HYPOGONADISM | 2015 |
|
RU2604681C1 |
